Corium Inc.
  • Who We Are
    • About Us
    • Leadership
    • Board of Directors
    • Our Mission & Values
  • What We Do
    • Our Products & Pipeline
    • Partnering
    • Our Proprietary Platforms
  • News & Media
  • Join Us
  • Contact Us
  • Who We Are
    • About Us
    • Leadership
    • Board of Directors
    • Our Mission & Values
  • What We Do
    • Our Products & Pipeline
    • Partnering
    • Our Proprietary Platforms
  • News & Media
  • Join Us
  • Contact Us

News & Media

June 13, 2018

By admin admin -

Corium Annouces Issuance of Key U.S. Patent Covering CorplexTM Donepezil Transdermal System for Alzheimer’s Disease
Provides Composition of Matter Coverage to 2037 MENLO PARK, Calif. , June 13, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced…

May 24, 2018

By admin admin -

Corium to Present at the Jefferies 2018 Global Healthcare Conference
MENLO PARK, Calif. , May 24, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple , Corium’s President and…

May 14, 2018

By admin admin -

Corium Reports Second Quarter Fiscal 2018 Finaical Results and Corporate Highlights
MENLO PARK, Calif. , May 14, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results for the second…

May 8, 2018

By admin admin -

Corium to Report Second Quarter Fiscal 2018 Financial Results on Monday, May 14, 2018
MENLO PARK, Calif. , May 08, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the second quarter ended March 31, 2018 on Monday, May 14, 2018 after the close of the U.S. financial markets. Corium will host a conference call…

March 19, 2018

By admin admin -

Corium to Present at the 17th Annual Needham Healthcare Conference
MENLO PARK, Calif. , March 19, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple , Corium’s President and…

Page 3 of 21‹12345›»
See all News

News Archive

  • Home
  • Who We Are
  • What We Do
  • News & Media
  • Join Us
  • Contact Us
  • Terms of Use
  • Privacy Policy








© 2020 Corium Inc. All rights reserved.